Litigation Details for Fresenius Kabi USA, LLC v. Eurohealth International Sarl (D. Del. 2018)
✉ Email this page to a colleague
Fresenius Kabi USA, LLC v. Eurohealth International Sarl (D. Del. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-06-01 |
| Court | District Court, D. Delaware | Date Terminated | 2018-08-14 |
| Cause | 35:1 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | FRESENIUS KABI USA, LLC | ||
| Patents | 9,248,229; 9,731,082 | ||
| Attorneys | Robert M. Vrana | ||
| Firms | Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Fresenius Kabi USA, LLC v. Eurohealth International Sarl
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Fresenius Kabi USA, LLC v. Eurohealth International Sarl (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-06-01 | 1 | Complaint | United States Patent No. 9,731,082 (“the ’082 patent”) and 9,248,229 (“the ’229 patent”). This action… ’082 patent and the ’229 patent. COUNT I: INFRINGEMENT OF THE ’082 PATENT …/mL prior the expiration of the ’082 patent and the ’229 patent. …5. This civil action for patent infringement arises under the patent laws of the United States, including… THE PATENT-IN-SUIT 11. The ’082 patent, entitled “Drug Container,” | External link to document |
| 2018-06-01 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,731,082 B2 ;US 9,248,229 B2. (jcs)…2018 14 August 2018 1:18-cv-00835 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
